Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone

BACKGROUND: There is no clear evidence whether pirfenidone has a benefit in patients with probable or possible UIP, i.e. when idiopathic pulmonary fibrosis (IPF) is diagnosed with a lower degree of diagnostic certainty. We report on outcomes of treatment with pirfenidone in IPF patients diagnosed wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Májek, Ondřej, Gregor, Jakub, Mogulkoć, Nesrin, Lewandowska, Katarzyna, Šterclová, Martina, Müller, Veronika, Hájková, Marta, Kramer, Mordechai R., Tekavec-Trkanjec, Jasna, Jovanović, Dragana, Studnicka, Michael, Stoeva, Natalia, Kirchgässler, Klaus-Uwe, Littnerová, Simona, Dušek, Ladislav, Vašáková, Martina Koziar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436039/
https://www.ncbi.nlm.nih.gov/pubmed/36048805
http://dx.doi.org/10.1371/journal.pone.0273854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436039/
https://www.ncbi.nlm.nih.gov/pubmed/36048805
http://dx.doi.org/10.1371/journal.pone.0273854

Ejemplares similares